{
  "docId": "019dd923-5eff-723e-9be5-b1dd64d43492",
  "docSlug": "1c070a4a766bdf1a",
  "documentTitle": "2024 Investor Day",
  "authorId": "Veeva",
  "authorName": "Veeva",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.778,
  "pageNumber": 15,
  "pageCount": 62,
  "prevPage": 14,
  "nextPage": 16,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "balanced",
  "nDataPoints": 5,
  "notes": "Uses a funnel-like visual to show the narrowing of the total market to the addressable market.",
  "elementsJson": [
    "donut_chart",
    "other"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5eff-723e-9be5-b1dd64d43492/15",
  "deckHref": "/decks/019dd923-5eff-723e-9be5-b1dd64d43492",
  "deckJsonHref": "/decks/019dd923-5eff-723e-9be5-b1dd64d43492.json",
  "deckAnchorHref": "/decks/019dd923-5eff-723e-9be5-b1dd64d43492#slide-15",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.145,
        "x": 0.82,
        "y": 0.275
      },
      "kind": "callout",
      "text": "~14% Penetrated FY25E Revenue",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3a423717-ea60-458c-a13a-edba22620e5a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.25,
        "x": 0.635,
        "y": 0.35
      },
      "kind": "chart",
      "text": "$20B+ TAM",
      "attrs": null,
      "subkind": "donut",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "72955b40-9b5c-4a77-8df5-e2d3cbf492f8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "TAM: $2T+",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-880d-72b9-8946-a01c60dda014",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.226,
        "w": 0.362,
        "x": 0.101,
        "y": 0.362
      },
      "kind": "paragraph",
      "text": "$2T+ 6%+ CAGR Biopharma • MedTech",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b3e9c10-4458-4004-9efe-5feba66b090b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.053,
        "w": 0.364,
        "x": 0.029,
        "y": 0.902
      },
      "kind": "source-note",
      "text": "Source: Evaluate and Veeva estimates\nTAM: Industry specific software, data, and high value services\nPenetration and FY25 revenue based on the high end of our guidance issued August 28, 2024",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ba44892-46b5-4153-8b5f-717923bb6ed6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.065,
        "w": 0.528,
        "x": 0.236,
        "y": 0.038
      },
      "kind": "title",
      "text": "Our Life Sciences Opportunity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fccb9267-fd4f-46df-80d2-b663dab43431",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 25,
      "from": 15,
      "beatId": "fa26f07d-0179-47db-bf15-803dc8332a27",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The presentation showcases Veeva's products, technology foundation, and growth prospects",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 8,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "2f99faaa-874c-4349-a82b-00988aefc022",
      "evidence": "The presentation outlines Veeva's product strategy and technology foundation",
      "position": 0,
      "objective": "To explain Veeva's product strategy and technology foundation",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 20,
      "from": 14,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "40431205-e43e-4f65-89ae-cb08a6663400",
      "evidence": "The presentation highlights the industry trends and Veeva's opportunity",
      "position": 1,
      "objective": "To highlight the importance of Veeva's products in the life sciences industry",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}